Interés Humano

FDA autoriza tercera dosis de Pfizer para personas mayores de 65 años y de alto riesgo

Un panel de expertos convocado por la agencia regulatoria estadounidense votó la semana pasada a favor de recomendar la medida

(FILES) In this file photo a syringe is filled with a first dose of the Pfizer Covid-19 vaccine at a mobile vaccination clinic at the Weingart East Los Angeles YMCA in Los Angeles, California on August 7, 2021. - The United States on September 22, 2021 authorized the use of boosters of Pfizer's Covid-19 vaccine for people aged over 65, people at high-risk of severe disease and those in high-exposure settings to the virus. (Photo by Patrick T. FALLON / AFP)
(FILES) In this file photo a syringe is filled with a first dose of the Pfizer Covid-19 vaccine at a mobile vaccination clinic at the Weingart East Los Angeles YMCA in Los Angeles, California on August 7, 2021. - The United States on September 22, 2021 authorized the use of boosters of Pfizer's Covid-19 vaccine for people aged over 65, people at high-risk of severe disease and those in high-exposure settings to the virus. (Photo by Patrick T. FALLON / AFP) PATRICK T. FALLON
‌
‌

‌

‌
‌

‌

‌